10.21147/j.issn.1000-9604.2017.01.03
Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
growth factor receptor、lung cancer、tyrosine kinase inhibitors、neuroendocrine carcinoma、treatment outcomes、squamous carcinoma、clinical features、Medical Sciences、disease control、response rate
29
R73;U
This study was supported by the funding from Chinese Geriatric Oncology Society CGOS H08151
2017-05-11(万方平台首次上网日期,不代表论文的发表时间)
共7页
18-24